| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
B and Expression of Fas Ligand in Thymic Stromal Cells and Consequent Apoptosis in T Cells1
Departments of*
Microbiology and Immunology and Pharmacology and Toxicology, Virginia Commonwealth University Medical Center, Richmond, VA 23298
We investigated the role of aryl hydrocarbon receptor (AhR) in the regulation of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD)-induced apoptosis in thymic T cells. AhR knockout (KO) mice were resistant to TCDD-induced thymic atrophy and apoptosis when compared with the AhR wild-type mice. TCDD triggered the expression of several apoptotic genes, including FasL in AhR wild-type but not AhRKO mice. TCDD-induced increase in FasL was seen only in thymic stromal but not thymic T cells. When TCDD-exposed stromal cells were mixed with untreated thymic T cells, increased apoptosis was detected in T cells that involved Fas-FasL interactions. Thus, apoptosis in T cells was not detected when TCDD-treated stromal cells from FasL-defective or AhRKO mice were mixed with wild-type T cells or when TCDD-exposed wild-type stromal cells were mixed with Fas-deficient T cells. TCDD treatment, in vivo and in vitro, led to colocalization and translocation of NF-
B subunits (p50, p65) to the nucleus in stromal but not T cells from AhR wild-type mice. NF-B activation was not observed in stromal cells isolated from TCDD-treated AhRKO mice. Mutations in NF-B-binding sites on the FasL promoter showed that TCDD regulates FasL promoter activity through NF-B. TCDD treatment in vivo caused activation of the death receptor and mitochondrial pathways of apoptosis. Cross-talk between the two pathways was not necessary for apoptosis inasmuch as TCDD-treated Bid KO mice showed thymic atrophy and increased apoptosis, similar to the wild-type mice. These findings demonstrate that AhR regulates FasL and NF-B in stromal cells, which in turn plays a critical role in initiating apoptosis in thymic T cells.
This article has been cited by other articles:
|
|
 |
|
  B. D. Hollingshead, T. V. Beischlag, B. C. DiNatale, P. Ramadoss, and G. H. Perdew Inflammatory Signaling and Aryl Hydrocarbon Receptor Mediate Synergistic Induction of Interleukin 6 in MCF-7 Cells Cancer Res., May 15, 2008; 68(10): 3609 - 3617. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. P. Hogaboam, A. J. Moore, and B. P. Lawrence The Aryl Hydrocarbon Receptor Affects Distinct Tissue Compartments during Ontogeny of the Immune System Toxicol. Sci., March 1, 2008; 102(1): 160 - 170. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. F. A. Vogel, E. Sciullo, W. Li, P. Wong, G. Lazennec, and F. Matsumura RelB, a New Partner of Aryl Hydrocarbon Receptor-Mediated Transcription Mol. Endocrinol., December 1, 2007; 21(12): 2941 - 2955. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. P. Singh, V. L. Hegde, L. J. Hofseth, M. Nagarkatti, and P. Nagarkatti Resveratrol (trans-3,5,4'-Trihydroxystilbene) Ameliorates Experimental Allergic Encephalomyelitis, Primarily via Induction of Apoptosis in T Cells Involving Activation of Aryl Hydrocarbon Receptor and Estrogen Receptor Mol. Pharmacol., December 1, 2007; 72(6): 1508 - 1521. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. P. Singh, M. Nagarkatti, and P. S. Nagarkatti Role of Dioxin Response Element and Nuclear Factor-{kappa}B Motifs in 2,3,7,8-Tetrachlorodibenzo-p-dioxin-Mediated Regulation of Fas and Fas Ligand Expression Mol. Pharmacol., January 1, 2007; 71(1): 145 - 157. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
